The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease.

Benjamin SahnYing LuJoyce S Hui-YuenJoanna FishbeinBeth S GottliebBarbara A EberhardHeather M Walters

Published in: Acta paediatrica (Oslo, Norway : 1992) (2022)

In our cohort of pediatric patients with IMID, observed side effects were found to be mild and disease flare rates were found to be low following COVID-19 vaccination.

Keyphrases

young adults
coronavirus disease
sars cov
oxidative stress
intensive care unit
mechanical ventilation